Application of honokiol and analogues thereof in preparation of medicines for resisting coronavirus 3CL protease
The invention discloses application of honokiol and analogues thereof in preparation of drugs for resisting coronavirus 3CL protease, and belongs to the technical field of medicines. In particular discloses application of honokiol and analogues thereof in preparation of medicines for preventing and/...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LI JIALIN ZHANG JIE ZHAO QIANQIAN DU CONG LU QI YANG XIUDING ZHOU YING LI JIAXUAN ZHAI XIAOPEI LIU YUTING LIU SUNDIAN GAO YUE ZHAO YUQING |
| description | The invention discloses application of honokiol and analogues thereof in preparation of drugs for resisting coronavirus 3CL protease, and belongs to the technical field of medicines. In particular discloses application of honokiol and analogues thereof in preparation of medicines for preventing and/or treating diseases caused by coronaviruses, and the coronaviruses which can be inhibited by the honokiol and the analogues thereof are SARS-CoV and SARS-CoV-2. It is found for the first time that honokiol and analogues thereof can play a role in resisting the coronavirus by inhibiting the coronavirus 3CL protease, the median inhibitory concentration of honokiol and analogues thereof on SARS-CoV and SARS-CoV-2 3CL protease is low, the coronavirus resisting effect is good, and therefore honokiol and analogues thereof can be used for preparing the medicine for preventing and/or treating new coronavirus infection.
本发明公开了和厚朴酚及其类似物在制备抗冠状病毒3CL蛋白酶药物中的应用，属于医药技术领域。具体公开了和厚朴酚及其类似物在制备预防和/或治疗冠状病毒所致疾病的药物中的应用，和厚朴酚及其类似物所能抑制的冠状病毒为 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN118403036A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN118403036A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN118403036A3</originalsourceid><addsrcrecordid>eNqNizEKwkAQRdNYiHqH8QBCworYhqBYiJV9GDaTOLjOLDsbz-8WYm3xecV_b1nFNsbAHjOrgI7wUNEnawCUoQyDTjMZ5AclKjcLxEQR0y940cCepTijJkhkbJllAq9JBd-cZgPXXUummdBoXS1GDEabL1fV9ny6d5cdRe3JInoSyn13a5rjvna1O7TuH-cDhKdDlw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Application of honokiol and analogues thereof in preparation of medicines for resisting coronavirus 3CL protease</title><source>esp@cenet</source><creator>LI JIALIN ; ZHANG JIE ; ZHAO QIANQIAN ; DU CONG ; LU QI ; YANG XIUDING ; ZHOU YING ; LI JIAXUAN ; ZHAI XIAOPEI ; LIU YUTING ; LIU SUNDIAN ; GAO YUE ; ZHAO YUQING</creator><creatorcontrib>LI JIALIN ; ZHANG JIE ; ZHAO QIANQIAN ; DU CONG ; LU QI ; YANG XIUDING ; ZHOU YING ; LI JIAXUAN ; ZHAI XIAOPEI ; LIU YUTING ; LIU SUNDIAN ; GAO YUE ; ZHAO YUQING</creatorcontrib><description>The invention discloses application of honokiol and analogues thereof in preparation of drugs for resisting coronavirus 3CL protease, and belongs to the technical field of medicines. In particular discloses application of honokiol and analogues thereof in preparation of medicines for preventing and/or treating diseases caused by coronaviruses, and the coronaviruses which can be inhibited by the honokiol and the analogues thereof are SARS-CoV and SARS-CoV-2. It is found for the first time that honokiol and analogues thereof can play a role in resisting the coronavirus by inhibiting the coronavirus 3CL protease, the median inhibitory concentration of honokiol and analogues thereof on SARS-CoV and SARS-CoV-2 3CL protease is low, the coronavirus resisting effect is good, and therefore honokiol and analogues thereof can be used for preparing the medicine for preventing and/or treating new coronavirus infection.
本发明公开了和厚朴酚及其类似物在制备抗冠状病毒3CL蛋白酶药物中的应用，属于医药技术领域。具体公开了和厚朴酚及其类似物在制备预防和/或治疗冠状病毒所致疾病的药物中的应用，和厚朴酚及其类似物所能抑制的冠状病毒为</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240730&DB=EPODOC&CC=CN&NR=118403036A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240730&DB=EPODOC&CC=CN&NR=118403036A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LI JIALIN</creatorcontrib><creatorcontrib>ZHANG JIE</creatorcontrib><creatorcontrib>ZHAO QIANQIAN</creatorcontrib><creatorcontrib>DU CONG</creatorcontrib><creatorcontrib>LU QI</creatorcontrib><creatorcontrib>YANG XIUDING</creatorcontrib><creatorcontrib>ZHOU YING</creatorcontrib><creatorcontrib>LI JIAXUAN</creatorcontrib><creatorcontrib>ZHAI XIAOPEI</creatorcontrib><creatorcontrib>LIU YUTING</creatorcontrib><creatorcontrib>LIU SUNDIAN</creatorcontrib><creatorcontrib>GAO YUE</creatorcontrib><creatorcontrib>ZHAO YUQING</creatorcontrib><title>Application of honokiol and analogues thereof in preparation of medicines for resisting coronavirus 3CL protease</title><description>The invention discloses application of honokiol and analogues thereof in preparation of drugs for resisting coronavirus 3CL protease, and belongs to the technical field of medicines. In particular discloses application of honokiol and analogues thereof in preparation of medicines for preventing and/or treating diseases caused by coronaviruses, and the coronaviruses which can be inhibited by the honokiol and the analogues thereof are SARS-CoV and SARS-CoV-2. It is found for the first time that honokiol and analogues thereof can play a role in resisting the coronavirus by inhibiting the coronavirus 3CL protease, the median inhibitory concentration of honokiol and analogues thereof on SARS-CoV and SARS-CoV-2 3CL protease is low, the coronavirus resisting effect is good, and therefore honokiol and analogues thereof can be used for preparing the medicine for preventing and/or treating new coronavirus infection.
本发明公开了和厚朴酚及其类似物在制备抗冠状病毒3CL蛋白酶药物中的应用，属于医药技术领域。具体公开了和厚朴酚及其类似物在制备预防和/或治疗冠状病毒所致疾病的药物中的应用，和厚朴酚及其类似物所能抑制的冠状病毒为</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNizEKwkAQRdNYiHqH8QBCworYhqBYiJV9GDaTOLjOLDsbz-8WYm3xecV_b1nFNsbAHjOrgI7wUNEnawCUoQyDTjMZ5AclKjcLxEQR0y940cCepTijJkhkbJllAq9JBd-cZgPXXUummdBoXS1GDEabL1fV9ny6d5cdRe3JInoSyn13a5rjvna1O7TuH-cDhKdDlw</recordid><startdate>20240730</startdate><enddate>20240730</enddate><creator>LI JIALIN</creator><creator>ZHANG JIE</creator><creator>ZHAO QIANQIAN</creator><creator>DU CONG</creator><creator>LU QI</creator><creator>YANG XIUDING</creator><creator>ZHOU YING</creator><creator>LI JIAXUAN</creator><creator>ZHAI XIAOPEI</creator><creator>LIU YUTING</creator><creator>LIU SUNDIAN</creator><creator>GAO YUE</creator><creator>ZHAO YUQING</creator><scope>EVB</scope></search><sort><creationdate>20240730</creationdate><title>Application of honokiol and analogues thereof in preparation of medicines for resisting coronavirus 3CL protease</title><author>LI JIALIN ; ZHANG JIE ; ZHAO QIANQIAN ; DU CONG ; LU QI ; YANG XIUDING ; ZHOU YING ; LI JIAXUAN ; ZHAI XIAOPEI ; LIU YUTING ; LIU SUNDIAN ; GAO YUE ; ZHAO YUQING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN118403036A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LI JIALIN</creatorcontrib><creatorcontrib>ZHANG JIE</creatorcontrib><creatorcontrib>ZHAO QIANQIAN</creatorcontrib><creatorcontrib>DU CONG</creatorcontrib><creatorcontrib>LU QI</creatorcontrib><creatorcontrib>YANG XIUDING</creatorcontrib><creatorcontrib>ZHOU YING</creatorcontrib><creatorcontrib>LI JIAXUAN</creatorcontrib><creatorcontrib>ZHAI XIAOPEI</creatorcontrib><creatorcontrib>LIU YUTING</creatorcontrib><creatorcontrib>LIU SUNDIAN</creatorcontrib><creatorcontrib>GAO YUE</creatorcontrib><creatorcontrib>ZHAO YUQING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LI JIALIN</au><au>ZHANG JIE</au><au>ZHAO QIANQIAN</au><au>DU CONG</au><au>LU QI</au><au>YANG XIUDING</au><au>ZHOU YING</au><au>LI JIAXUAN</au><au>ZHAI XIAOPEI</au><au>LIU YUTING</au><au>LIU SUNDIAN</au><au>GAO YUE</au><au>ZHAO YUQING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Application of honokiol and analogues thereof in preparation of medicines for resisting coronavirus 3CL protease</title><date>2024-07-30</date><risdate>2024</risdate><abstract>The invention discloses application of honokiol and analogues thereof in preparation of drugs for resisting coronavirus 3CL protease, and belongs to the technical field of medicines. In particular discloses application of honokiol and analogues thereof in preparation of medicines for preventing and/or treating diseases caused by coronaviruses, and the coronaviruses which can be inhibited by the honokiol and the analogues thereof are SARS-CoV and SARS-CoV-2. It is found for the first time that honokiol and analogues thereof can play a role in resisting the coronavirus by inhibiting the coronavirus 3CL protease, the median inhibitory concentration of honokiol and analogues thereof on SARS-CoV and SARS-CoV-2 3CL protease is low, the coronavirus resisting effect is good, and therefore honokiol and analogues thereof can be used for preparing the medicine for preventing and/or treating new coronavirus infection.
本发明公开了和厚朴酚及其类似物在制备抗冠状病毒3CL蛋白酶药物中的应用，属于医药技术领域。具体公开了和厚朴酚及其类似物在制备预防和/或治疗冠状病毒所致疾病的药物中的应用，和厚朴酚及其类似物所能抑制的冠状病毒为</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN118403036A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Application of honokiol and analogues thereof in preparation of medicines for resisting coronavirus 3CL protease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T21%3A59%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LI%20JIALIN&rft.date=2024-07-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN118403036A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |